Remove 2018 Remove Compounding Remove Patient Care
article thumbnail

3D printing and personalised medicines: embracing innovative technologies

Hospital Pharmacy Europe

Supporting the successful compounding of drugs with 3D printing processes has the potential to not only fulfil unmet patient needs but also drive efficiencies in hospital pharmacies. The adaptability of 3D printing allows for a rapid response to varying demands, mitigating the impact of shortages on patient care.

Hospitals 111
article thumbnail

Too Much of a Good Thing? Unpacking the Rise of Polypharmacy in Seniors

PharmD Live

Understanding the balance between essential and excessive polypharmacy, recognizing its prevalence, and identifying contributing factors are crucial in mitigating its risks and enhancing patient care. “Health Literacy and Its Impact on Medication Adherence,” Pharmacy Journal , 2018). According to the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

5 Tips for Pharmacy Students APPE Rotations

The Luxe Pharmacist

If you plan on pursuing a different area like retail, compounding, etc take full advantage of any relationship you can make in those areas. Throwbacks from my APPE year – 2018 to 2019. The overall perception of you will follow you throughout your career, so make sure it’s a good one. APPE Rotation Essentials.

article thumbnail

Solutions for Constipation Relief

The Thyroid Pharmacist

One 2018 study found that among 80 people with IBS, 19 percent had undiagnosed thyroid dysfunction. [11] Take this month to recognize their expertise and the valuable support they provide in patient care! [9] Additionally, constipation can be associated with an “official diagnosis” of constipation-predominant IBS (IBS-C). [10]

article thumbnail

Clinical service provision and workforce capacity require improvement in hospital pharmacy, EAHP finds

Hospital Pharmacy Europe

Similar findings were observed in previous iterations of the survey in 2016, 2017/18 and 2018/19. Few barriers were identified for hospital pharmacies to engage in the procurement, compounding and the distribution of medicines.

article thumbnail

DEA’s Expected Guidance: It Should Reduce Current “Pain” at the (Intrathecal Pain) Pump Dispensing Process and Improve Therapeutic Outcomes

The FDA Law Blog

This lifesaving and life-sustaining option is reserved for a small but highly vulnerable population of approximately 130,000 patients suffering from severe chronic pain due to, for example, spinal cord injuries, amputation, cancer, or spasticity caused by multiple sclerosis. However, two events conspired to undermine this prior guidance.